跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
EYDENZELT aflibercept (rch) 40 mg/mL solution for intravitreal injection pre-filled syringe - TGA Drug Approval Details
Approvals
/
TGA
/
EYDENZELT aflibercept (rch) 40 mg/mL solution for intravitreal injection pre-filled syringe
Approved
STANDARD
EYDENZELT aflibercept (rch) 40 mg/mL solution for intravitreal injection pre-filled syringe
Celltrion Healthcare Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
274fefa524cff369
Company
Celltrion Healthcare Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
274fefa524cff369
Product Name
EYDENZELT aflibercept (rch) 40 mg/mL solution for intravitreal injection pre-filled syringe
Artg Id
431931
Artg Name
EYDENZELT aflibercept (rch) 40 mg/mL solution for intravitreal injection pre-filled syringe
Sponsor
Celltrion Healthcare Australia Pty Ltd
Company Detail Path
/organization/celltrion-healthcare-australia-pty-ltd
Artg Date
2025-03-31
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Product Information
https://medical-cdn.nocode.com/drug_tga/d8d79383fd0ee213996df167e9677e0a.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
274fefa524cff369
Type
Standard
Back to TGA Approvals